Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › NY › Corona › NPI 1639765704
NP / PA

Mujtaba NP in Family Health, P.C.

Mujtaba NP in Family Health, P.C. was paid $432K by Medicaid between Mar 2022 and Dec 2024, across 21 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 39% of everything it billed.

33Billing provider infoMUJTABA NP IN FAMILY HEALTH, P.C.
CORONA, NY 11368
33aNPI1639765704assigned 12/14/2020
28Total paid$432K
24GClaims8,570
24DCodes billed21
24AFirst – last monthMar 2022 – Dec 2024
Compared with peers

Next to other Family Nurse Practitioner providers in New York

Rank by total paid#22 of 1,582
Median peer was paid$2K
This provider vs. median188×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$20K$40K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20224,064$236K
20232,751$122K
2024incomplete1,755$74K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 39% 2,819 2,387 $168K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV 15% 481 464 $65K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 14% 591 567 $59K
99203 Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity 11% 609 607 $49K
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 11% 626 575 $48K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 2.9% 1,303 1,234 $12K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 1.5% 200 192 $7K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 1.5% 195 183 $6K
99204 Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 1.4% 44 44 $6K
90674 <1% 106 106 $3K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 140 139 $2K
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) <1% 147 142 $2K
9 more codes
99050 <1% 713 $851.41
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 104 $819.78
0124A <1% 26 $786.72
90658 <1% 35 $559.42
93000 <1% 25 $323.38
87428 <1% 16 $213.06
36415 Collection of venous blood by venipuncture <1% 225 $121.20
99051 <1% 138 $117.04
91312 <1% 27 $16.56

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialMUJTABA, ATHAR (CEO/PROVIDER)